Entry |
|
Name |
Mavodelpar (USAN/INN) |
Formula |
C31H30FNO5
|
Exact mass |
515.2108
|
Mol weight |
515.57
|
Structure |
|
Remark |
|
Efficacy |
Peroxisome proliferator-activated receptor (PPAR) delta agonist |
Comment |
Treatment of fatty acid oxidation disorders
|
Target |
|
Pathway |
|
Brite |
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Peroxisome proliferator-activated receptor (PPAR)
NR1C3 (PPARG)
D12644 Mavodelpar (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 38
1 O2a O 19.8471 -15.6393
2 C8y C 21.0394 -16.3406
3 C8x C 21.0394 -17.7432
4 C8y C 22.3017 -18.4445
5 C8y C 23.4940 -17.7432
6 C8x C 23.4940 -16.3406
7 C8x C 22.3017 -15.6393
8 C1a C 22.3017 -19.8471
9 O2a O 24.7563 -18.4445
10 C1b C 25.9486 -17.7432
11 C6a C 27.1408 -18.4445
12 O6a O 28.3330 -17.7432
13 O6a O 27.1408 -19.8471
14 C1b C 18.6664 -16.3079
15 C2b C 18.6664 -17.7079
16 C2c C 17.4709 -18.3983
17 C8y C 16.2853 -17.7139
18 C8y C 17.4708 -19.8097
19 C8x C 16.2803 -20.4972
20 C8x C 16.2805 -21.8972
21 C8y C 17.4930 -22.5971
22 C8x C 18.6835 -21.9095
23 C8x C 18.6833 -20.5095
24 X F 17.4931 -24.0100
25 C8x C 16.2851 -16.3102
26 C8x C 15.0726 -15.6104
27 C8y C 13.8603 -16.3105
28 C8x C 13.8604 -17.7142
29 C8x C 15.0729 -18.4141
30 C3b C 12.6473 -15.6104
31 C3b C 11.4349 -14.9104
32 C1b C 10.2225 -14.2104
33 N1y N 9.0084 -14.9114
34 C1x C 7.8117 -14.2203
35 C1x C 6.5992 -14.9202
36 O2x O 6.5990 -16.3202
37 C1x C 7.7957 -17.0112
38 C1x C 9.0082 -16.3114
BOND 41
1 1 2 1
2 2 3 2
3 3 4 1
4 4 5 2
5 5 6 1
6 6 7 2
7 2 7 1
8 4 8 1
9 5 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 11 13 2
14 1 14 1
15 14 15 1
16 15 16 2
17 16 17 1
18 16 18 1
19 18 19 2
20 19 20 1
21 20 21 2
22 21 22 1
23 22 23 2
24 18 23 1
25 21 24 1
26 17 25 2
27 25 26 1
28 26 27 2
29 27 28 1
30 28 29 2
31 17 29 1
32 27 30 1
33 30 31 3
34 31 32 1
35 32 33 1
36 33 34 1
37 34 35 1
38 35 36 1
39 36 37 1
40 37 38 1
41 33 38 1
|